Immunosuppressive therapy does not prevent the occurrence of immunoglobulin E-mediated allergies in children and adolescents with organ transplants

Pediatrics

Volumn 118, Issue 3, 2006, Pages

  Dehlink, Eleonora ^a   Gruber, Saskia ^a   Eiwegger, Thomas ^a   Gruber, Diego ^a   Mueller, Thomas ^a   Huber, Wolf Dietrich ^a   Klepetko, Walter ^a   Rumpold, Helmut ^a   Urbanek, Radvan ^a   Szépfalusi, Zsolt ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Allergy; Children; IgE; Immunosuppression; Sensitization; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; FOOD ALLERGEN; HISTAMINE; IMMUNOGLOBULIN E; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; SODIUM CHLORIDE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ANAPHYLAXIS; ARTICLE; ATOPY; CHILD; FEMALE; GRAFT REJECTION; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOSUPPRESSIVE TREATMENT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; RISK FACTOR; ALLOTRANSPLANTATION; CROSS-SECTIONAL STUDY; HYPERSENSITIVITY; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; ORGAN TRANSPLANTATION; REGRESSION ANALYSIS; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33749066010     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-0370     Document Type: Article

References (33)

1. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med. 1989;110:1001-1016
2. Penn I. De novo malignances in pediatric organ transplant recipients. Pediatr Transplant. 1998;2:56-63
3. Kelly DA. Optimal immunosuppression in teenagers. Pediatr Transplant. 2002;6:480-487
4. Arikan C, Kilic M, Tokat Y, Aydogdu S. Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine A therapy. Transplant Proc. 2003;35:3039-3041
5. Boyle R, Hardikar W, Tang M. The development of food allergy after liver transplantation. Liver Transpl. 2005;11:326-330
6. Chehade M, Nowak-Wegrzyn A, Kaufman S, Fishbein T, Tschernia A, LeLeiko N. De novo food allergy after intestinal transplantation: a report of three cases. J Pediatr Gastroenterol Nutr. 2004;38:545-547
7. Gennery AR, Cant AJ. Development of allergy post-bone marrow transplantation. Clin Exp Allergy. 2002;32:1677-1678
8. Lacaille F, Laurent J, Bousquet J. Life-threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr. 1997;25:228-229
9. Legendre C, Caillat-Zucman S, Samuel D, et al. Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. N Engl J Med. 1997;337:822-824
10. Nowak-Wegrzyn A, Sicherer S, Conover-Walker M, Wood R. Food allergy after pediatric organ transplantation with tacrolimus immunosuppression. J Allergy Clin Immunol. 2001;108:146-147
11. Phan T, Strasser S, Koorey D, et al. Passive transfer of nut allergy after liver transplantation. Arch Intern Med. 2003;163:237-239
12. Rietz H, Plummer A, Gal A. Asthma as a consequence of bone marrow transplantation. Chest. 2002;122:369-370
13. Trotter JF, Everson GT, Bock SA, Wachs M, Bak T, Kam I. Transference of peanut allergy through liver transplantation. Liver Transpl. 2001;7:1088-1089
14. Lykavieris P, Frauger E, Habes D, Bernard O, Debray D. Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. Transplantation. 2003;75:152-155
15. Pacifico L, Frediani T, Simonetti A, Chiesa C, Cucchiara S. Tacrolimus and food allergy. Transplantation. 2003;76:1778
16. Lechler R, Sykes M, Thomson A, Turka L. Organ-transplantation: how much of the promise has been realized? Nat Med. 2005;11:605-613
17. Umetsu D, DeKruyff R. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc Soc Exp Biol Med. 1997;215:11-20
18. Berth-Jones J, Graham-Brown RA, Marks R, et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol. 1997;136:76-81
19. Berth-Jones J, Takwale A, Tan E, et al. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol. 2002;147:324-330
20. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Arch Dermatol. 2001;137:870-873
21. Hanifin JM, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis [published correction appears in J Am Acad Dermatol. 2005;52:156]. J Am Acad Dermatol. 2004;50:391-404
22. Neuber K, Schwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol. 2000;143:385-391
23. Nizankowska E, Soja J, Pinis G, et al. Treatment of steroid-dependent bronchial asthma with cyclosporin. Eur Respir J. 1995;8:1091-1099
24. Sihra BS, Kon OM, Durham SR, Walker S, Barnes NC, Kay AB. Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax. 1997;52:447-452
25. Sowden JM, Berth-Jones J, Ross JS, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet. 1991;338:137-140
26. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J. 1995;8:483-491
27. Kjellman N, Johansson S, Roth A. Serum IgE levels in healthy children quantified by a sandwich technique (PRIST). Clin Allergy. 1976;6:51-59
28. Position paper: allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology. Allergy. 1993;48(14 suppl):48-82
29. Mortz CG, Lauritsen JM, Andersen KE, Bindslev-Jensen C. Type I sensitization in adolescents: prevalence and association with atopic dermatitis. The Odense Adolescence Cohort Study on atopic diseases and dermatitis (TOACS). Acta Derm Venerol. 2003;83:194-201
30. Weiland SK, von Mutius E, Hirsch T, et al. Prevalence of respiratory and atopic disorders among children in the East and West of Germany five years after unification. Eur Respir J. 1999;14:862-870
31. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1225-1232
32. Gabe SM, Bjarnason I, Tolou-Ghamari Z, et al. The effect of tacrolimus (FK 506) on intestinal barrier function and cellular energy production in humans. Gastroenterology. 1998;115:67-74
33. Kawamura N, Furuta H, Tame A, et al. Extremely high serum level of IgE during immunosuppressive therapy: paradoxical effect of cyclosporine A and tacrolimus. Int Arch Allergy Immunol. 1997;112:422-424